References
1. Siegel R, DeSantis C, Jemal A. Colorectal cancer statistics, 2014. CA: A Cancer Journal for Clinicians. 2014;64(2):104-117.doi:10.3322/caac.21220.
2. Figueredo A, Coombes ME, Mukherjee S. Adjuvant Therapy for completely resected Stage II Colon Cancer. Cochrane Database of Systematic Reviews. 2008(3).doi:10.1002/14651858.CD005390.pub2.
3. Cohen AM, Kelsen D, Saltz L, et al. Adjuvant therapy for colorectal cancer. Current Problems in Surgery. 1997;34(8):601-676.doi:https://doi.org/10.1016/S0011-3840(97)80013-5.
4. Weixler B, Warschkow R, Güller U, et al. Isolated tumor cells in stage I & II colon cancer patients are associated with significantly worse disease-free and overall survival. BMC Cancer. 2016;16(1):106.doi:10.1186/s12885-016-2130-7.
5. Mescoli C, Albertoni L, Pucciarelli S, et al. Isolated Tumor Cells in Regional Lymph Nodes as Relapse Predictors in Stage I and II Colorectal Cancer. Journal of Clinical Oncology. 2012;30(9):965-971.doi:10.1200/jco.2011.35.9539.
6. Saha S, Elgamal M, Cherry M, et al. Challenging the conventional treatment of colon cancer by sentinel lymph node mapping and its role of detecting micrometastases for adjuvant chemotherapy. Clinical & Experimental Metastasis. 2018;35(5):463-469.doi:10.1007/s10585-018-9927-5.
7. Hermanek P, Hutter RV, Sobin LH, et al. International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer. 1999;86(12):2668-2673.
8. Braat AE, Oosterhuis JW, de Vries JE, et al. Lymphatic staging in colorectal cancer: pathologic, molecular, and sentinel node techniques. Diseases of the colon and rectum. 2005;48(2):371-383.doi:10.1007/s10350-004-0796-4.
9. Borgstein PJMD, Pijpers RMD, Comans EFMD, et al. Sentinel Lymph Node Biopsy in Breast Cancer: Guidelines and Pitfalls of Lymphoscintigraphy and Gamma Probe Detection. Journal of the American College of Surgeons. 1998;186(3):275-283.doi:10.1016/S1072-7515(98)00011-8.
10. Koyanagi K, Bilchik AJ, Saha S, et al. Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial. Clin Cancer Res. 2008;14(22):7391-7396.doi:10.1158/1078-0432.CCR-08-0290.
11. Whiting P, Rutjes AWS, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25-25.doi:10.1186/1471-2288-3-25.
12. Albayrak Y, Oren D, Gundogdu C, et al. Intraoperative sentinel lymph node mapping in patients with colon cancer: study of 38 cases. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology. 2011;22(3):286-292.doi:10.4318/tjg.2011.0214.
13. Andersen HS, Bennedsen ALB, Burgdorf SK, et al. In vivo and ex vivo sentinel node mapping does not identify the same lymph nodes in colon cancer. Int J Colorectal Dis. 2017;32(7):983-990.doi:10.1007/s00384-017-2777-9.
14. Bartels SAL, van der Zaag ES, Dekker E, et al. The effect of colonoscopic tattooing on lymph node retrieval and sentinel lymph node mapping. Gastrointestinal Endoscopy. 2012;76(4):793-800.doi:10.1016/j.gie.2012.05.005.
15. Bell SW, Mourra N, Flejou JF, et al. Ex vivo sentinel lymph node mapping in colorectal cancer. Diseases of the colon and rectum. 2005;48(1):74-79.doi:10.1007/s10350-004-0782-x.
16. Bembenek A, Rau B, Moesta T, et al. Sentinel lymph node biopsy in rectal cancer&x2014;Not yet ready for routine clinical use. Surgery. 2004;135(5):498-505.doi:10.1016/j.surg.2003.10.004.
17. Bembenek AE, Rosenberg R, Wagler E, et al. Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg. 2007;245(6):858-863.doi:10.1097/01.sla.0000250428.46656.7e.
18. Bertagnolli M, Miedema B, Redston M, et al. Sentinel node staging of resectable colon cancer: results of a multicenter study. Ann Surg. 2004;240(4):624-630.doi:10.1097/01.sla.0000140753.41357.20.
19. Bertoglio S, Sandrucci S, Percivale P, et al. Prognostic value of sentinel lymph node biopsy in the pathologic staging of colorectal cancer patients. Journal of Surgical Oncology. 2004;85(3):166-170.doi:10.1002/jso.20030.
20. Bianchi PP, Petz W, Casali L. Laparoscopic lymphatic roadmapping with blue dye and radioisotope in colon cancer. Colorectal Disease. 2011;13(s7):67-69.doi:10.1111/j.1463-1318.2011.02786.x.
21. Bilchik AJ, Nora DT, Sobin LH, et al. Effect of Lymphatic Mapping on the New Tumor-Node-Metastasis Classification for Colorectal Cancer. Journal of Clinical Oncology. 2003;21(4):668-672.doi:10.1200/jco.2003.04.037.
22. Broderick-Villa G, Ko A, O'Connell TX, et al. Does tumor burden limit the accuracy of lymphatic mapping and sentinel lymph node biopsy in colorectal cancer? Cancer journal (Sudbury, Mass.). 2002;8(6):445-450.doi:10.1097/00130404-200211000-00008.
23. Chan SH, Ng C, Looi LM. Intraoperative methylene blue sentinel lymph node mapping in colorectal cancer. ANZ journal of surgery. 2008;78(9):775-779.doi:10.1111/j.1445-2197.2008.04648.x.
24. Codignola C, Zorzi F, Zaniboni A, et al. Is there any Role for Sentinel Node Mapping in Colorectal Cancer Staging? Personal Experience and Review of the Literature. Japanese Journal of Clinical Oncology. 2005;35(11):645-650.doi:10.1093/jjco/hyi182.
25. Cox ED, Kellicut D, Adair C, et al. Sentinel lymph node evaluation is technically feasible and may improve staging in colorectal cancer. Current surgery. 2002;59(3):301-306.doi:10.1016/s0149-7944(01)00639-0.
26. Cserni G, Vajda K, Tarjan M, et al. Nodal staging of colorectal carcinomas from quantitative and qualitative aspects. Can lymphatic mapping help staging? Pathology oncology research : POR. 1999;5(4):291-296.doi:10.1053/paor.1999.0205.
27. Currie AC, Brigic A, Thomas-Gibson S, et al. A pilot study to assess near infrared laparoscopy with indocyanine green (ICG) for intraoperative sentinel lymph node mapping in early colon cancer. European Journal of Surgical Oncology. 2017;43(11):2044-2051.doi:10.1016/j.ejso.2017.05.026.
28. Dahl K, Westlin J, Kraaz W, et al. Identification of sentinel nodes in patients with colon cancer. European Journal of Surgical Oncology. 2005;31(4):381-385.doi:10.1016/j.ejso.2004.12.015.
29. de Haas RJ, Wicherts DA, Hobbelink MGG, et al. Sentinel lymph node mapping in colon cancer using radiocolloid as a single tracer: a feasibility study. Nuclear Medicine Communications. 2012;33(8):832-837.doi:10.1097/MNM.0b013e328353bc0c.
30. Demirbas S, Ince M, Baloglu H, et al. Should sentinel lymph node mapping be performed for colorectal cancer? The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology. 2004;15(1):39-44.
31. Esser S, Reilly WT, Riley LB, et al. The role of sentinel lymph node mapping in staging of colon and rectal cancer. Diseases of the colon and rectum. 2001;44(6):850-854; discussion 854-856.doi:10.1007/bf02234707.
32. Estrada O, Pulido L, Admella C, et al. Sentinel lymph node biopsy as a prognostic factor in non-metastatic colon cancer: a prospective study. Clinical and Translational Oncology. 2017;19(4):432-439.doi:10.1007/s12094-016-1543-8.
33. Faerden AE, Sjo OH, Andersen SN, et al. Sentinel node mapping does not improve staging of lymph node metastasis in colonic cancer. Diseases of the colon and rectum. 2008;51(6):891-896.doi:10.1007/s10350-007-9185-0.
34. Finan KR, Lewis JS, Jr., Winslow E, et al. Ex vivo sentinel lymph node mapping in patients undergoing proctectomy for rectal cancer. Diseases of the colon and rectum. 2010;53(3):243-250.doi:10.1007/DCR.0b013e3181c3822b.
35. Gandy CP, Biddlestone LR, Roe AM, et al. Intra-operative injection of Patent Blue V dye to facilitate nodal staging in colorectal cancer. Colorectal Disease. 2002;4(6):447-449.doi:10.1046/j.1463-1318.2002.00391.x.
36. Hirche C, Mohr Z, Kneif S, et al. Ultrastaging of colon cancer by sentinel node biopsy using fluorescence navigation with indocyanine green. Int J Colorectal Dis. 2012;27(3):319-324.doi:10.1007/s00384-011-1306-5.
37. Ivanov K, Kolev N, Ignatov V, et al. Intraoperative sentinel lymph node mapping in patients with colorectal cancer. Hepato-gastroenterology. 2009;56(89):99-105.
38. Joosten JJA, Strobbe LJA, Wauters CAP, et al. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. BJS (British Journal of Surgery). 1999;86(4):482-486.doi:10.1046/j.1365-2168.1999.01051.x.
39. Kelder W, Braat AE, Karrenbeld A, et al. The sentinel node procedure in colon carcinoma: a multi-centre study in The Netherlands. Int J Colorectal Dis. 2007;22(12):1509-1509.doi:10.1007/s00384-007-0351-6.
40. Khafagy W, El-Dawoody A, El-Ghawalby N, et al. Ultrastaging of Rectal Cancer Based on Identification of Micrometastases in Sentinel Lymph Node. coloproctology. 2005;27(3):153-160.doi:10.1007/s00053-005-5164-x.
41. Kitagawa Y, Watanabe M, Hasegawa H, et al. Sentinel node mapping for colorectal cancer with radioactive tracer. Diseases of the colon and rectum. 2002;45(11):1476-1480.doi:10.1007/s10350-004-6453-0.
42. Koksal H, Bostanci H, Mentes BB. Importance of sentinel lymph nodes in colorectal cancer: a pilot study. Advances in therapy. 2007;24(3):583-588.doi:10.1007/bf02848781.
43. Kusano M, Tajima Y, Yamazaki K, et al. Sentinel Node Mapping Guided by Indocyanine Green Fluorescence Imaging: A New Method for Sentinel Node Navigation Surgery in Gastrointestinal Cancer. Digestive Surgery. 2008;25(2):103-108.doi:10.1159/000121905.
44. Liberale G, Lasser P, Sabourin JC, et al. Sentinel lymph nodes of colorectal carcinoma: reappraisal of 123 cases. Gastroenterologie clinique et biologique. 2007;31(3):281-285.doi:10.1016/s0399-8320(07)89374-2.
45. Lim SJ, Feig BW, Wang H, et al. Sentinel Lymph Node Evaluation Does Not Improve Staging Accuracy in Colon Cancer. Annals of Surgical Oncology. 2008;15(1):46-51.doi:10.1245/s10434-007-9629-8.
46. Matter M, Winckler M, Aellen S, et al. Detection of metastatic disease with sentinel lymph node dissection in colorectal carcinoma patients. European Journal of Surgical Oncology. 2007;33(10):1183-1190.doi:10.1016/j.ejso.2007.03.019.
47. Merrie AE, van Rij AM, Phillips LV, et al. Diagnostic use of the sentinel node in colon cancer. Diseases of the colon and rectum. 2001;44(3):410-417.doi:10.1007/bf02234742.
48. Murawa D, Filas V, Breborowicz J, et al. Evaluation of the sentinel node biopsy in colorectal carcinoma including the results of immunohistochemical examinations. Acta chirurgica Belgica. 2007;107(1):45-48.doi:10.1080/00015458.2007.11680009.
49. Nordgård O, Oltedal S, Aasprong OG, et al. Prognostic Relevance of Occult Metastases Detected by Cytokeratin 20 and Mucin 2 mRNA Levels in Sentinel Lymph Nodes from Colon Cancer Patients. Annals of Surgical Oncology. 2012;19(12):3719-3726.doi:10.1245/s10434-012-2454-8.
50. Oh SY, Kim DY, Kim YB, et al. Clinical application of sentinel lymph node mapping in colon cancer: in vivo vs. ex vivo techniques. Ann Surg Treat Res. 2014;87(3):118-122.doi:10.4174/astr.2014.87.3.118.